The abstract is read at the publisher; the summary is JClub's.
An updated kidney replacement Roadmap calls for integrative, patient-centered strategies that merge engineering, biology, and design to accelerate translation of next-generation therapies.
- Why it matters: Precision medicine has advanced disease-specific treatments, but moving next-generation kidney replacement approaches into real-world practice has lagged. The Roadmap targets this translation gap while emphasizing mobility, sustainability, and quality of life.
- What they did: It outlines directions including biomimetic membranes, cellular systems, and organ-on-chip technologies, alongside microbiome modulation and sorbent-based approaches to reduce uraemic toxin burden. It also highlights xenotransplantation and stem cell regeneration as biologic frontiers.
- The result: The Roadmap argues that renewed investment, regulatory clarity, and cross-sector collaboration—embedded with patient perspectives—are needed to deliver equitable, wearable or implantable solutions beyond the clinic. It notes ongoing challenges in safety, equity, and scalability.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.